ATLASATLAS fair value
CN¥15.07
Close to fair value · 2% premium
Range: CN¥11–CN¥20Fair valuePrice
Jafron Biomedical (300529.SHE)
Jafron Biomedical stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Shenzhen Stock Exchange · China
CN¥15.30▼ -1.92%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Jafron Biomedical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Jafron Biomedical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Jafron Biomedical's fair value at about CN¥15.07 per share (reasonable range: CN¥10.50 to CN¥20.06). At CN¥15.30, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Jafron Biomedical a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥14.53 and CN¥16.17; in 9 out of 10, between CN¥13.22 and CN¥17.78. Estimated annual volatility is 29%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥11.8B
- Market cap (USD)
- $1.8B
- P/E ratio
- 22.8
- Dividend yield
- 3.41%
- 52-week high
- CN¥21.52
- 52-week low
- CN¥14.60
- Revenue (12 months)
- CN¥1.9B
- Gross margin
- 76.8%
- Operating margin
- 36.8%
- Net margin
- 27.5%
- Beta
- 0.38
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Jafron Biomedical sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 300529.SHE has traded between CN¥14.60 and CN¥21.52. Today it is 28.9% below that high and 5% above its low.
On the business: net margin is 27.5%; it trades at 22.8 times earnings.
Its beta is 0.38: it tends to move less than the market.
About the company
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning.
Want to see everything about Jafron Biomedical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Jafron Biomedical (300529.SHE) fair value?
About CN¥15.07 per share according to ATLAS (reasonable range: CN¥10.50 to CN¥20.06). With the stock at CN¥15.30, it is close to that value.
What is the chance 300529.SHE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, 300529.SHE ends the month between CN¥14.53 and CN¥16.17.
How big is Jafron Biomedical and what is its P/E ratio?
Jafron Biomedical's market capitalization is CN¥11.8B. Its price-to-earnings (P/E) ratio is 22.8: you pay CN¥22.8 for each CN¥1.00 of yearly earnings.
Does Jafron Biomedical pay a dividend?
Yes. 300529.SHE's current dividend yield is 3.41% at today's price (CN¥15.30).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer